A growing number of individuals are turning to microdosing weight-loss medications in an effort to manage their weight with minimal side effects. This approach, which involves taking significantly lower doses
Continue readingThe Rise of Microdosing Weight-Loss Drugs: Does It Really Work?
Semaglutide just obtained a new FDA approval aimed at addressing chronic kidney disease (CKD) in patients with Type 2 diabetes. This latest endorsement positions Ozempic as the most widely indicated
Continue readingSemaglutide FDA Approval for Kidney Disease Risk Reduction
Emerging research suggests that GLP-1 drugs—commonly used for managing diabetes and obesity—may also support brain health. Semaglutide-based drugs like Ozempic and Wegovy, as well as tirzepatide (Zepbound), may provide neuroprotective benefits that go beyond their well-known effects on weight loss. …
Continue readingGLP-1 Drugs like Ozempic May Protect Brain Health.
While GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound and their alternative compounded versions Tirzepatide and Semaglutide, are widely known for their effectiveness in managing type 2 diabetes and aiding
Continue reading3 Additional Benefits of GLP-1 Drugs Beyond Weight Loss
Over the past few years, the demand for new weight loss medications has skyrocketed, particularly for anti-obesity drugs like semaglutide (Wegovy) and tirzepatide (Zepbound). Known as glucagon-like peptide 1 (GLP-1)
Medications like Ozempic, Wegovy, or their compounded parts Semaglutide, and Tirzepatide originally developed to treat diabetes and obesity, are now showing potential for preventing certain types of cancer. These drugs,
Continue readingGLP-1 Drugs Like Semaglutide and Tirzepatide May Help Reduce Cancer Risk
GLP-1 drugs, such as Ozempic, Wegovy, and Mounjaro, or the compounded versions Tirzepatide and Semaglutide have long been used to treat diabetes and aid in weight loss. However, new research
Continue readingGLP-1 Drugs Could Prevent 34,000 Heart Attacks and Strokes Each Year
A new Cleveland Clinic study has revealed key factors that influence long-term weight loss in people using GLP-1 receptor agonist (RA) medications like semaglutide (Wegovy, Ozempic) and liraglutide (Saxenda, Victoza).
Continue readingWith Everything Worth Fighting For, Persistence is Key!
In light of recent FDA alerts regarding dosing errors associated with compounded injectable semaglutide products, our clinic has reaffirmed our commitment to patient safety, efficacy, and adherence to medical standards
Continue readingReflection on the Importance of Pre-Filling Syringes at Our Clinic
The rise of “Ozempic babies” has garnered attention nationwide, spotlighting the unexpected link between GLP-1 medications, weight loss, and enhanced fertility. Originally developed for diabetes management, GLP-1 receptor agonists (GLP-1 RAs) like Ozempic, Wegovy, Mounjaro, and Zepbound have also shown surprising benefits, including significant weight loss, improved cardiovascular and kidney health, and now, a possible boost in fertility. …